Merger communication
Open the filing on sec.gov
Personalis, Inc. (PSNL)
Nasdaq: PSNL · Services-Medical Laboratories · Fremont, CA · filing with the SEC since 2011
The companyfiscal 2025, as filed
Revenue$69.6M-17.7%
Net income-$81.3M+0.0%
Earnings per share$-0.91+33.6%
Operating cash flow-$74.9M-66.0%
Cash$124M+35.9%
Debtn/a
Shareholders’ equity$261M+28.7%
Shares, diluted89.2M+50.6%
Return on equity-31.1%
The recordfrom its filings
Filings in 202690
Newest filingNov 12 · 425
Annual reportFeb 26, 2026
Quarterly reportNov 4, 2026
Next report due10-K by Mar 31
Insider sales, 12 months$9.0M
Insider buys, 12 months$0.00
Patents granted39
Filer categoryNon-accelerated filer<br>Smaller reporting company
Trailing twelve months to Sep 2026Revenue $80.8MNet income -$119MCash from operations -$97.6Mthe four newest filed quarters added
Left: the newest annual report, with the change on the year before. Right: counted from the company's own filings with the SEC.
As filed, in USD. Nothing here is a forecast.
News
Merger communication
Open the filing on sec.gov
Insider trade report
Open the filing on sec.gov
Quarterly report
Open the filing on sec.gov
Results released
Open the filing on sec.gov
Merger communication
Open the filing on sec.gov
Merger communication
Open the filing on sec.gov
Merger proxy statement
Open the filing on sec.gov
Merger communication
Open the filing on sec.gov
Merger communication
Open the filing on sec.gov
Nothing of this kind is on the record for this company yet.
An outside story is shown by its headline, its source and its link only. The SI reads the page when you ask it to break one down.